Liraglutide is supplied in 6 mg/mL multi-dose pen. The standard approach is daily injection titrated weekly from 0.6 mg to 3.0 mg
Strength and use
| Strength | Typical role |
|---|---|
| 6 mg/mL multi-dose pen | Starting or low-dose maintenance |
Titration path
- 1
Step 1: initiate
Begin at the lowest useful strength of 6 mg/mL multi-dose pen.
- 2
Step 2: assess
Review after the onset window of appetite effect within the first week.
- 3
Step 3: escalate
Move up one strength only if the response is partial and tolerance is good.
- 4
Step 4: maintain
Hold at the lowest effective dose for weight management and type 2 diabetes and review periodically.
Key takeaways
- Standard dosing: daily injection titrated weekly from 0.6 mg to 3.0 mg
- Dosing interval: 24 hours, daily dosing.
- Never double up after a missed dose: resume the normal schedule.
- Store 2–8 °C cold chain until first use to protect potency across the shelf life.
Missed doses and adherence
If a dose is missed and the next one is close, skip it. Doubling increases the risk of nausea without improving outcomes. Blister packaging and clear dispensing labels measurably improve adherence on prefilled pen lines.
Liraglutide at a glance
| Attribute | Detail |
|---|---|
| Drug class | GLP-1 receptor agonist |
| Common brand | Saxenda / Victoza |
| Licensed use | weight management and type 2 diabetes |
| Available strengths | 6 mg/mL multi-dose pen |
| Dosage form | prefilled pen |
| Typical onset | appetite effect within the first week |
| Duration / dosing interval | 24 hours, daily dosing |
| Storage | 2–8 °C cold chain until first use |